Benzinga · Mar 5, 2026
OS
NASDAQ · OSRH
OSR Holdings, Inc.
Healthcare · Biotechnology
$0.12
Up+$0.00 (+0.00%)
Updated Sep 16, 2026, 12:49 PM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 16.52M
- P/E ratio
- -0.84
- Dividend yield
- 0.00%
- 52-week range
- $0.08 – $0.90
- Volume
- 27.45M
- Avg. volume
- 4.96M
Price performance
OSRH price history
1M range · 6 trading sessions · Daily adjusted prices
OSRH closed at $0.12 after 6 trading sessions, down 72.91% for the selected period.
- Last close
- $0.12
- Period change
- -72.91%
- Period low
- $0.12
- Period high
- $0.43
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | $0.2205 | $0.255 | $0.0827 | $0.1165 | 27.45M |
| Aug 24, 2026 | $0.28 | $0.3043 | $0.242 | $0.25 | 4.01M |
| Aug 21, 2026 | $0.2991 | $0.33 | $0.2693 | $0.277 | 4.99M |
| Aug 20, 2026 | $0.308 | $0.3387 | $0.2752 | $0.2949 | 6.27M |
| Aug 19, 2026 | $0.425 | $0.5127 | $0.37 | $0.3731 | 22.23M |
| Aug 18, 2026 | $0.6432 | $0.84 | $0.3658 | $0.43 | 146.88M |
Latest OSRH news
The latest Smart Investors Daily articles mentioning OSRH.
Stock researchCompany · Overview
OSRH research
Overview
Company profile and research snapshot.
Company profile
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Benzinga · Mar 5, 2026
OSR Holdings Receives Written Notification From The Nasdaq Granting The Company An Additional 180-Calendar-Day Extension To Regain Compliance
OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare holding company advancing innovative biomedical technologies, today announced that it has received written notification from The Nasdaq Stock Market LLC granting the
GlobeNewswire Inc. · Dec 10, 2025
Presenting on Emerging Growth Conference 88 Day 2 on December 11; Register to live stream
EmergingGrowth.com announced the schedule for its 88th conference featuring presentations from multiple public companies across various sectors on December 10-11, 2025, providing investors an opportunity to learn about emerging growth companies.
globenewswire.com · Dec 9, 2025
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
MIAMI, Dec. 09, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth. com a leading independent small cap media portal announces the schedule of the 88th Emerging Growth Conference on December 10 and 11, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products and services, focused strategy, execution, and the overall potential for long-term growth.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
